Author
Listed:
- Meaghan Boileau
(McGill University and McGill University Heath Centre Research Institute)
- Margret Shirinian
(American University of Beirut
American University of Beirut)
- Tenzin Gayden
(McGill University)
- Ashot S. Harutyunyan
(McGill University)
- Carol C. L. Chen
(McGill University)
- Leonie G. Mikael
(McGill University and McGill University Heath Centre Research Institute)
- Heather M. Duncan
(McGill University and McGill University Heath Centre Research Institute)
- Andrea L. Neumann
(Research Institute of the McGill University Health Centre and McGill University)
- Patricia Arreba-Tutusaus
(Research Institute of the McGill University Health Centre and McGill University)
- Nicolas Jay
(McGill University
Jewish General Hospital)
- Michele Zeinieh
(McGill University)
- Katya Rossokhata
(McGill University)
- Yelu Zhang
(Research Institute of the McGill University Health Centre and McGill University)
- Hamid Nikbakht
(McGill University
McGill University and Génome Québec Innovation Centre)
- Carine Mouawad
(American University of Beirut)
- Radwan Massoud
(American University of Beirut)
- Felice Frey
(American University of Beirut)
- Rihab Nasr
(American University of Beirut)
- Jean El Cheikh
(American University of Beirut)
- Marwan El Sabban
(American University of Beirut)
- Claudia L. Kleinman
(McGill University
Jewish General Hospital)
- Rami Mahfouz
(American University of Beirut)
- Mark D. Minden
(University of Toronto
University of Toronto)
- Nada Jabado
(McGill University
McGill University and McGill University Heath Centre Research Institute)
- Ali Bazarbachi
(American University of Beirut
American University of Beirut)
- Kolja Eppert
(McGill University and McGill University Heath Centre Research Institute)
Abstract
Our ability to manage acute myeloid leukemia (AML) is limited by our incomplete understanding of the epigenetic disruption central to leukemogenesis, including improper histone methylation. Here we examine 16 histone H3 genes in 434 primary AML samples and identify Q69H, A26P, R2Q, R8H and K27M/I mutations (1.6%), with higher incidence in secondary AML (9%). These mutations occur in pre-leukemic hematopoietic stem cells (HSCs) and exist in the major leukemic clones in patients. They increase the frequency of functional HSCs, alter differentiation, and amplify leukemic aggressiveness. These effects are dependent on the specific mutation. H3K27 mutation increases the expression of genes involved in erythrocyte and myeloid differentiation with altered H3K27 tri-methylation and K27 acetylation. The functional impact of histone mutations is independent of RUNX1 mutation, although they at times co-occur. This study establishes that H3 mutations are drivers of human pre-cancerous stem cell expansion and important early events in leukemogenesis.
Suggested Citation
Meaghan Boileau & Margret Shirinian & Tenzin Gayden & Ashot S. Harutyunyan & Carol C. L. Chen & Leonie G. Mikael & Heather M. Duncan & Andrea L. Neumann & Patricia Arreba-Tutusaus & Nicolas Jay & Mich, 2019.
"Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness,"
Nature Communications, Nature, vol. 10(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10705-z
DOI: 10.1038/s41467-019-10705-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10705-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.